This report provides a comprehensive overview of the methamphetamine market in the European Union. It assesses the current threat situation regarding current trends in production, trafficking and distribution (EMCDDA)
Bibliography: International Policy Issues
EU Drug Markets Report 2019
The EU Drug Markets Report 2019 is the third comprehensive overview of illicit drug markets in the European Union by the EMCDDA and Europol.
Position of the European Society for Prevention Research on ineffective and potentially harmful approaches in substance use prevention
Prevention methods using shock tactics are proven to be ineffective. Nevertheless, strategies based on predominantly providing information about the dangers of substance use are widespread in Europe (European Society for Prevention Research)
The Reitox network: frequently asked questions
This information brochure has been produced by the EMCDDA to provide answers to the most commonly asked questions on the Reitox network of national focal points and more broadly on national drugs observatories (EMCDDA)
HIV and people who inject drugs (PDF)
Monitoring implementation of the Dublin Declaration on partnership to fight HIV/AIDS in Europe and Central Asia: 2018 progress report (ecdc)
Monitoring the elimination of viral hepatitis as a public health threat among people who inject drugs in Europe
This technical report focuses on an elimination barometer for viral hepatitis to help countries assess progress towards eliminating hepatitis C and B among people who inject drugs (PWID). The barometer is being developed by the EMCDDA together with its expert network on drug-related infectious diseases (DRID), as a follow-up to the first global health sector strategy on viral hepatitis endorsed by the World Health Assembly in 2016 (EMCDDA)
Healthy, prosperous lives for all: the European Health Equity Status Report (PDF)
This report identifies five essential conditions needed to create and sustain a healthy life for all: good quality and accessible health services; income security and social protection; decent living conditions; social and human capital and decent work and employment conditions. Policy actions are needed to address all five conditions (WHO)
Frequently asked questions (FAQ): drug overdose deaths in Europe
This page provides an update on drug-related deaths in Europe, presenting and analysing the latest data on and trends in drug-induced deaths in the European Union, Norway and Turkey. It draws on contributions from specialists from these countries, as well as on information provided by European countries in the annual reporting exercise to the agency (EMCDDA)
Latest update on drug-related deaths and mortality in Europe
The information provided in the report is collected through the EMCDDA’s expert network on drug-related deaths (DRD)
Serbia — Early warning system profile
The profile presents the structure, objectives and working methods of the Serbian national early warning system (EMCDDA)
Drug-related infectious diseases in Europe: update from the EMCDDA expert network
This report presents an overview of infectious diseases among people who inject drugs in Europe, both in the community and in prison settings, covering disease surveillance, outbreak investigations, and prevention and control, for the period up to the end of February 2019 (EMCDDA)
World Drug Report 2019
Presented in five separate parts that divide the wealth of information and analysis contained in the report into individual reader-friendly booklets in which drugs are grouped by their psychopharmacological effect for the first time in the report’s history (UNODC)
Classification of Drugs: when science was left behind,
The first-ever comprehensive report providing a political reading of the current evaluation and classification, or “scheduling” of drugs according to their harms (The Global Commission on Drug Policy)
Developments in the European cannabis market
This paper provides an overview of established and emerging cannabis products in Europe. For each type of product, major issues in its production, distribution, use and effects on health are detailed. In doing so, the paper seeks to inform a discussion of the new challenges that may emerge in the monitoring of these products and the consequences of their use (EMCDDA)
The International Narcotics Control Board on cannabis: A critique of the report for 2018
As can be seen over the past 45 years or so, the potency of the Report has arguably shifted away from the public and more towards influencing opinion within the UN’s central policy-making body on the issue of drugs, the Commission on Narcotic Drugs (IDPC)
General Report of Activities 2018 – Key achievements and governance: a year in review
The General Report of Activities is an annual publication providing a detailed progress report of the EMCDDA’s activities over a 12-month period. It catalogues the Centre’s achievements in each area of its annual work programme (EMCDDA)
European Drug Report 2019: Trends and Developments
he Trends and Developments report presents a top-level overview of the drug phenomenon in Europe, covering drug supply, use and public health problems as well as drug policy and responses. Together with the online Statistical Bulletin and 30 Country Drug Reports, it makes up the 2019 European Drug Report package – Download (EMCDDA)
Drugs in syringes from six European cities: results from the ESCAPE project 2017
In this pilot study, chemical analysis of the contents of used syringes collected from exchange sites reveals the drugs and drug combinations injected in the six participating European cities (EMCDDA)
Addressing Problematic Opioid Use in OECD Countries
This report presents evidence on the magnitude of problematic opioid use across OECD countries
Global Drug Survey – main findings (PDF)
Using data from the GDS2019 sample we ranked 13 drugs in terms of the percentage of people who recently used that drug, reported seeking emergency medical treatment (EMT) in the last 12 months. Download full PDF
- « Previous Page
- 1
- 2
- 3
- 4
- …
- 12
- Next Page »
